Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)

CUSIP: 30050B101

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding
112,318,617
Total 13F shares
122,283,963
Share change
-7,560,479
Total reported value
$1,375,271,472
Put/Call ratio
71%
Price per share
$11.25
Number of holders
237
Value change
-$248,054,960
Number of buys
133
Number of sells
137

Quarterly Holders Quick Answers

What is CUSIP 30050B101?
CUSIP 30050B101 identifies EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
11%
12,595,459
$356,199,581 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
9.7%
10,911,418
$308,574,901 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
7.8%
8,798,311
$248,816,236 30 Sep 2024
13F
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G
Company
3.1%
from 13D/G
8,514,862
$240,800,297 30 Sep 2024
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
13F
Company
4.4%
4,939,306
$139,683,574 30 Sep 2024
13F
FMR LLC
13F
Company
3.9%
4,332,229
$122,515,450 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
3.7%
4,116,045
$116,401,751 30 Sep 2024
13F
Engaged Capital LLC
13F
Company
3.6%
3,989,468
$112,822,155 30 Sep 2024
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
3.4%
3,804,104
$107,580,061 30 Sep 2024
13F
Granahan Investment Management, LLC
13F
Company
3.1%
3,491,817
$98,748,585 30 Sep 2024
13F
STATE STREET CORP
13F
Company
2.4%
2,725,375
$77,073,605 30 Sep 2024
13F
Bellevue Group AG
13F
Company
2.4%
2,670,050
$75,509,014 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.2%
2,520,818
$71,303,055 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2.2%
2,431,218
$68,762,246 30 Sep 2024
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
2.1%
2,371,052
$67,053,000 30 Sep 2024
13F
First Light Asset Management, LLC
13F
Company
2%
2,298,261
$64,994,821 30 Sep 2024
13F
BLAIR WILLIAM & CO/IL
13F
Company
1.9%
2,156,115
$60,974,918 30 Sep 2024
13F
Rock Springs Capital Management LP
13F
Company
1.8%
2,070,000
$58,539,600 30 Sep 2024
13F
Holocene Advisors, LP
13F
Company
1.8%
2,044,606
$57,821,458 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
1.7%
1,898,399
$53,686,716 30 Sep 2024
13F
ORBIMED ADVISORS LLC
13F
Company
1.5%
1,665,115
$47,089,452 30 Sep 2024
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
1.4%
1,516,544
$42,887,870 30 Sep 2024
13F
Point72 Asset Management, L.P.
13F
Company
1.3%
1,495,385
$42,289,489 30 Sep 2024
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
1.3%
1,420,387
$40,168,544 30 Sep 2024
13F
Camber Capital Management LP
13F
Company
1.2%
1,400,000
$39,592,000 30 Sep 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
1.2%
1,380,184
$39,031,634 30 Sep 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
1.2%
1,364,298
$38,582,348 30 Sep 2024
13F
NORGES BANK
13F
Company
1.2%
1,347,256
$38,100,400 30 Sep 2024
13F
Invesco Ltd.
13F
Company
1.2%
1,293,345
$36,575,798 30 Sep 2024
13F
Hood River Capital Management LLC
13F
Company
1.2%
1,292,379
$36,548,478 30 Sep 2024
13F
Boston Partners
13F
Company
1.1%
1,272,702
$35,053,888 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
1%
1,177,814
$33,308,581 30 Sep 2024
13F
SILVERCREST ASSET MANAGEMENT GROUP LLC
13F
Company
0.89%
998,260
$28,230,793 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.81%
912,395
$25,802,531 30 Sep 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.81%
909,776
$24,682,223 30 Sep 2024
13F
Frank J. Williams
3/4/5
Director
mixed-class rows
903,126
mixed-class rows
$24,140,121 01 Jun 2023
ZEVENBERGEN CAPITAL INVESTMENTS LLC
13F
Company
0.67%
753,038
$21,295,915 30 Sep 2024
13F
GABELLI FUNDS LLC
13F
Company
0.64%
721,500
$20,404,020 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.64%
715,905
$20,247,000 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.63%
702,545
$19,867,973 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.62%
694,234
$19,632,937 30 Sep 2024
13F
JENNISON ASSOCIATES LLC
13F
Company
0.58%
646,806
$18,291,674 30 Sep 2024
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.57%
639,000
$18,070,920 30 Sep 2024
13F
MACQUARIE GROUP LTD
13F
Company
0.56%
631,584
$17,861,000 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.54%
610,746
$17,271,897 30 Sep 2024
13F
GLENMEDE TRUST CO NA
13F
Company
0.45%
503,823
$14,248,113 30 Sep 2024
13F
Man Group plc
13F
Company
0.44%
491,382
$13,896,283 30 Sep 2024
13F
Rock Point Advisors, LLC
13F
Company
0.41%
465,782
$13,172,315 30 Sep 2024
13F
HARBOR CAPITAL ADVISORS, INC.
13F
Company
0.38%
422,421
$11,946,000 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.37%
420,321
$11,886,678 30 Sep 2024
13F

Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q4 2024

As of 31 Dec 2024, Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by 237 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,283,963 shares. The largest 10 holders included VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., Engaged Capital LLC, CADIAN CAPITAL MANAGEMENT, LP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, EVENTIDE ASSET MANAGEMENT, LLC, FMR LLC, Camber Capital Management LP, and Granahan Investment Management, LLC. This page lists 238 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
255
Q4 2024 holders
237
Holder diff
-18
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .